{"meta":{"query_hash":"bc7c9cf051d7","filters":{"venue":"Proceedings of 6th International Electronic Conference on Medicinal Chemistry"},"cohort_total":3,"direct_labels_cover":0,"predictions_cover":3,"exported":3,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/bc7c9cf051d7","api":"https://metacan.xera.ac/api/v1/cohort?venue=Proceedings+of+6th+International+Electronic+Conference+on+Medicinal+Chemistry"},"results":[{"id":"W3134069745","doi":"10.3390/ecmc2020-07368","title":"A robust bioassay of the human bradykinin B<sub>2</sub> receptor that extends molecular/cellular studies: The isolated umbilical vein","year":2020,"lang":"en","type":"article","venue":"Proceedings of 6th International Electronic Conference on Medicinal Chemistry","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Bradykinin; Agonist; Chemistry; Pharmacology; Kallidin; G protein-coupled receptor; Receptor; Kallikrein; Antagonist; Biochemistry; Biology; Kinin; Enzyme","score_opus":0.07050241447521009,"score_gpt":0.30275462097051664,"score_spread":0.23225220649530653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3134069745","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.39114812,0.036019135,0.5275739,0.0018036553,0.001747261,0.0018043814,0.005679793,0.0022837978,0.031939957],"genre_scores_gemma":[0.73833597,0.016569702,0.2054924,0.0009475263,0.00053830334,0.0018422133,0.009754007,0.00019203463,0.02632787],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992867,0.0001978627,0.000062969295,0.00015542036,0.00021566254,0.000081356404],"domain_scores_gemma":[0.9997706,0.00005436279,0.000043700733,0.000038985992,0.000039236194,0.00005309396],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006996045,0.00090501434,0.00040044784,0.00039230537,0.0001908685,0.00057420763,0.0006621583,0.0008036071,0.002670263],"category_scores_gemma":[0.0005061788,0.00023241322,0.0004105686,0.00035294515,0.00030544036,0.0003419611,0.00041024623,0.001321408,0.002281115],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007471269,0.00006133748,0.0001440394,0.00011300942,0.00001046575,0.000054029202,0.000019643505,0.000042585318,0.9935768,0.00040770412,0.00039829157,0.0050973785],"study_design_scores_gemma":[0.000029894867,0.0008072026,0.0020901652,0.000024260633,0.000037034915,0.00077451335,0.000025643698,0.00073656056,0.9798544,0.00012259782,0.015483444,0.000014280218],"about_ca_topic_score_codex":0.00033015778,"about_ca_topic_score_gemma":0.00048808297,"teacher_disagreement_score":0.002670263,"about_ca_system_score_codex":0.0002620806,"about_ca_system_score_gemma":0.00041156413,"threshold_uncertainty_score":0.0089328885},"labels":[],"label_agreement":null},{"id":"W3134203110","doi":"10.3390/ecmc2020-08493","title":"Disease-modifying therapy for Alzheimer’s","year":2020,"lang":"en","type":"article","venue":"Proceedings of 6th International Electronic Conference on Medicinal Chemistry","topic":"Cholinesterase and Neurodegenerative Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"","keywords":"Disease; Computer science; Medicine; Internal medicine","score_opus":0.0999211071498804,"score_gpt":0.3480420235099638,"score_spread":0.24812091636008343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3134203110","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.32426128,0.60519844,0.007517295,0.0031939787,0.0010920005,0.00058271474,0.0020251067,0.00056666887,0.055562507],"genre_scores_gemma":[0.7353202,0.21828969,0.008565134,0.0024993538,0.0004162457,0.0002489206,0.002458502,0.000028214014,0.032173596],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999641,0.000006899823,0.000002969213,0.00000589727,0.000011792139,0.000008329453],"domain_scores_gemma":[0.9999801,0.0000027141937,0.0000052722603,0.0000017338863,0.0000053398794,0.000004896496],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012574357,0.00021012938,0.00029970863,0.00030951735,0.00014973144,0.00020699759,0.00021367923,0.00019770388,0.004863654],"category_scores_gemma":[0.00009153327,0.000047482266,0.00022915665,0.00025276133,0.000087680906,0.00014776122,0.0001461817,0.00037365544,0.0012486023],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012518987,0.0012961935,0.0017848267,0.0026333367,0.00018088658,0.0012904704,0.00013626067,0.00078818056,0.24834068,0.0030510759,0.021197284,0.71804893],"study_design_scores_gemma":[0.0016964782,0.012878799,0.013771345,0.00066277274,0.0005720415,0.0061536045,0.00013345882,0.0029384051,0.16265306,0.002457603,0.7960282,0.000054196666],"about_ca_topic_score_codex":0.0004040406,"about_ca_topic_score_gemma":0.0018524907,"teacher_disagreement_score":0.004863654,"about_ca_system_score_codex":0.0001760384,"about_ca_system_score_gemma":0.00015211277,"threshold_uncertainty_score":0.016270518},"labels":[],"label_agreement":null},{"id":"W3134394078","doi":"10.3390/ecmc2020-07300","title":"Drug repurposing: Dipeptidyl peptidase IV (DPP4) inhibitors as potential agents to treat SARS-CoV-2 (2019-nCov) infection","year":2020,"lang":"en","type":"article","venue":"Proceedings of 6th International Electronic Conference on Medicinal Chemistry","topic":"Peptidase Inhibition and Analysis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"University of Waterloo","keywords":"Drug repositioning; Repurposing; Dipeptidyl peptidase-4; Medicine; Linagliptin; Pharmacology; Drug; Coronavirus; Protease inhibitor (pharmacology); Type 2 diabetes; Type 2 Diabetes Mellitus; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Virology; Diabetes mellitus; Coronavirus disease 2019 (COVID-19); Viral load; Disease; Biology; Infectious disease (medical specialty); Internal medicine; Virus","score_opus":0.021892653993919695,"score_gpt":0.3007277571145415,"score_spread":0.2788351031206218,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3134394078","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90650785,0.055431176,0.020060807,0.0008706952,0.00022202823,0.00029585938,0.0023362066,0.0006138955,0.013661353],"genre_scores_gemma":[0.95019805,0.025105378,0.019200385,0.00048638321,0.00006624106,0.00012072885,0.0021601606,0.000044459255,0.0026182353],"study_design_codex":"simulation_or_modeling","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9999156,0.000017827077,0.0000050588433,0.000017614579,0.000023831888,0.000020084486],"domain_scores_gemma":[0.9999491,0.000014348455,0.0000149696025,0.0000028162747,0.000007885516,0.000010863129],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023972802,0.0006513778,0.00093660183,0.00042700677,0.00023605658,0.00068177574,0.00045638555,0.00039784634,0.0029403067],"category_scores_gemma":[0.000285408,0.0001865903,0.0010906403,0.00042732278,0.0001552988,0.00045524904,0.00037505387,0.00052891026,0.00044070708],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032725204,0.0025830094,0.01864388,0.006559719,0.0015014694,0.0056086075,0.0001448182,0.41789767,0.2292857,0.010945368,0.013969514,0.2895877],"study_design_scores_gemma":[0.0026190176,0.015521917,0.016218547,0.00072229886,0.0031980344,0.004519941,0.000545308,0.6973961,0.17091642,0.009563697,0.078484185,0.00029455352],"about_ca_topic_score_codex":0.0013637409,"about_ca_topic_score_gemma":0.0020696456,"teacher_disagreement_score":0.0029403067,"about_ca_system_score_codex":0.00023099977,"about_ca_system_score_gemma":0.00043323424,"threshold_uncertainty_score":0.0098362565},"labels":[],"label_agreement":null}]}